GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » ROC %

Cian Healthcare (BOM:542678) ROC % : 8.62% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cian Healthcare ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Cian Healthcare's annualized return on capital (ROC %) for the quarter that ended in Mar. 2024 was 8.62%.

As of today (2024-06-21), Cian Healthcare's WACC % is 4.06%. Cian Healthcare's ROC % is 20.13% (calculated using TTM income statement data). Cian Healthcare generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Cian Healthcare ROC % Historical Data

The historical data trend for Cian Healthcare's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cian Healthcare ROC % Chart

Cian Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROC %
Get a 7-Day Free Trial Premium Member Only 3.23 0.50 0.20 5.42 20.17

Cian Healthcare Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.71 10.57 5.15 3.64 8.62

Cian Healthcare ROC % Calculation

Cian Healthcare's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2024 is calculated as:

ROC % (A: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2023 ) + Invested Capital (A: Mar. 2024 ))/ count )
=53.969 * ( 1 - -387.16% )/( (1320.511 + 1287.107)/ 2 )
=262.9153804/1303.809
=20.17 %

where

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1604.796 - 270.989 - ( 13.296 - max(0, 652.664 - 742.436+13.296))
=1320.511

Invested Capital(A: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1611.757 - 312.709 - ( 11.941 - max(0, 661.116 - 717.426+11.941))
=1287.107

Cian Healthcare's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=73.004 * ( 1 - -53.38% )/( (1310.993 + 1287.107)/ 2 )
=111.9735352/1299.05
=8.62 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1631.171 - 311.576 - ( 8.602 - max(0, 705.834 - 787.42+8.602))
=1310.993

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1611.757 - 312.709 - ( 11.941 - max(0, 661.116 - 717.426+11.941))
=1287.107

Note: The Operating Income data used here is two times the semi-annual (Mar. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cian Healthcare  (BOM:542678) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Cian Healthcare's WACC % is 4.06%. Cian Healthcare's ROC % is 20.13% (calculated using TTM income statement data). Cian Healthcare generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Cian Healthcare ROC % Related Terms

Thank you for viewing the detailed overview of Cian Healthcare's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cian Healthcare (BOM:542678) Business Description

Traded in Other Exchanges
N/A
Address
Vitthal Rao Shivarkar Road, Office No. 508-511, 5th Floor, Sacred World, Above Macdonald, Wanowrie, Pune, MH, IND, 411040
Cian Healthcare Ltd is a fully integrated pharmaceutical company. It is engaged in the research, development, and manufacturing of different forms of tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets. The company's portfolio comprises of gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotics, CNS, vitamins, and nutrient products. It operates in five sectors namely Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party. The majority of the revenue is generated from the Indian Market.

Cian Healthcare (BOM:542678) Headlines

No Headlines